Experience. Commitment. Results.
Kezar Life Sciences, Inc. (NASDAQ: KZR) related to its sale to Aurinia Pharmaceuticals Inc. Under the terms of the proposed transaction, Kezar shareholders are expected to receive $6.955 per share in cash and one non-transferable contingent value right.
Olaplex Holdings, Inc. (NASDAQ: OLPX) related to its sale to Henkel US Operations Corporation. Under the terms of the proposed transaction, Olaplex shareholders are expected to receive $2.06 per share in cash.
Corebridge Financial, Inc. (NYSE: CRBG) related to its merger with Equitable Holdings, Inc. Upon closing of the proposed transaction, Corebridge shareholders will own approximately 51% of the combined company.
Equitable Holdings, Inc. (NYSE: EQH) related to its merger with Corebridge Financial, Inc. Upon closing of the proposed transaction, Equitable shareholders will own approximately 49% of the combined company.
Terns Pharmaceuticals, Inc. (NASDAQ: TERN) related to its sale to Merck Sharp & Dohme LLC. Under the terms of the proposed transaction, Terns shareholders are expected to receive $53.00 per share in cash.
Warner Bros. Discovery, Inc. (NASDAQ: WBD) related to its sale to Paramount Skydance Corporation. Under the terms of the proposed transaction, Warner Bros. shareholders are expected to receive (i) $31.00 per share in cash and (ii) a ticking consideration of $0.00277778 multiplied by the number of calendar days elapsed after September 30, 2026.
HCB Financial Corp. (OTCPK: HCBN) related to its merger with Independent Bank Corporation. Under the terms of the proposed transaction, HCB shareholders are expected to receive 1.5900 shares of Independent common stock and $17.51 for each share of HCB common stock.
Independent Bank Corporation (NASDAQ: IBCP) related to its sale to HCB Financial Corp. Under the terms of the proposed transaction, HCB shareholders are expected to receive 1.5900 shares of Independent common stock and $17.51 for each share of HCB common stock.
Rallybio Corporation (NASDAQ: RLYB) related to its merger with Candid Therapeutics, Inc. Upon completion of the proposed transaction, Rallybio shareholders are expected to own approximately 3.65% of the combined company.
National Storage Affiliates Trust (NYSE: NSA) related to its sale to Public Storage. Under the terms of the proposed transaction, National Storage shareholders are expected to receive 0.14 of a share of Public Storage common stock or partnership units for each National Storage share or unit.